home / stock / cfrx / cfrx news

CFRX News and Press, ContraFect Corporation From 04/18/23

Stock Information
Company Name: ContraFect Corporation
Stock Symbol: CFRX
Market: NASDAQ
Website: contrafect.com
Menu
CFRX CFRX Quote CFRX Short CFRX News CFRX Articles CFRX Message Board
Get CFRX Alerts

News, Short Squeeze, Breakout and More Instantly...
CFRX - Dermata, Bellus top healthcare gainers; China Jo-Jo Drugstores, ContraFect among losers

2023-04-18 10:04:36 ET Gainers: Dermata Therapeutics ( DRMA ) +108% . BELLUS Health ( BLU ) +99% . Allarity Therapeutics ( ALLR ) +69% . Gamida Cell ( GMDA ) +37% . YS Biopharma ( YS ) +28% . Losers: China Jo-Jo Drugs...
CFRX - WINT, CFRX and WISA among pre-market losers

2023-04-18 08:30:29 ET China Jo-Jo Drugstores ( CJJD ) -36% . Athersys ( ATHX ) -33% announces $3.7 million registered direct Offering and concurrent private placement. Presto Automation ( PRST ) -20% . Evaxion Biotech ( EVAX ) -20% promis...

CFRX - The Future of Buying Penny Stocks: Trends for 2023

2023-04-18 07:00:00 ET 3 Future Trends to Use for Your Penny Stocks Investing This Year The allure of penny stocks has captivated investors for years, and with good reason. These low-priced stocks offer the potential for exponential gains, often within a relatively short period. As the ...

CFRX - Ocean Biomedical, ContraFect top healthcare gainers; GlucoTrack, ViewRay among losers

2023-04-13 10:02:55 ET Gainers: Ocean Biomedical ( OCEA ) +24% . ContraFect ( CFRX ) +21% . bluebird bio ( BLUE ) +18% . Evaxion Biotech ( EVAX ) +17% . Hillstream BioPharma ( HILS ) +10% . Losers: GlucoTrack ( GCTK ) ...
CFRX - BTBT, TUP and BITF are among pre market gainers

2023-04-13 08:20:45 ET CXApp  ( CXAI ) +56% . Ocean Biomedical ( OCEA ) +20% a nnounces notice of allowance for U.S. patent application for developing “whole new class” of Malaria therapeutics issued to scientific co-founder Dr. Jonathan Kurtis. ...

CFRX - ContraFect Announces Multiple Presentations of New Data at the 33rd Annual ECCMID Meeting

Oral Presentation of New Data Demonstrating the Activity of Lysin CF-370 Against XDR Pseudomonas aeruginosa New Data Elucidating the Mechanism of Action of CF-370 YONKERS, N.Y., April 06, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) , a clinical...

CFRX - ContraFect Announces Initiation of a Phase 1b/2 Study of Exebacase in Patients with Chronic Prosthetic Joint Infections of the Knee

YONKERS, New York, April 03, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatmen...
CFRX - Contrafect GAAP EPS of -$16.14

2023-03-31 08:43:34 ET Contrafect press release ( NASDAQ: CFRX ): Q4 GAAP EPS of -$16.14. The net loss in the current period includes $4.8 million, or $7.90 per share, of non-cash charges related to the value of the warrants issued in the Company’s December 2022 off...

CFRX - ContraFect Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Provides Business Update

YONKERS, N.Y., March 31, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatmen...

CFRX - Cardio Diagnostics, Bioventus top healthcare gainers; ContraFect, AdaptHealth among losers

Gainers: Cardio Diagnostics ( CDIO ) +159% . Bioventus ( BVS ) +68% . CNS Pharmaceuticals ( CNSP ) +24% . Bullfrog AI ( BFRG ) +20% . SI-BONE ( SIBN ) +19% . Losers: ContraFect ( CFRX ) -24% . AdaptHealth ( AHCO ) ...
Previous 10 Next 10